Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew E Place

Showing results (1-10 of 55) with videos related to

Pageof 6
Sort By:
Breast Cancer Research : BCR|November 15, 2011
The microenvironment in breast cancer progression: biology and implications for treatmentAndrew E Place, Sung Jin Huh, Kornelia Polyak
British Journal of Haematology|September 7, 2013
Therapeutic approaches to haematological malignancies in adolescents and young adultsAndrew E Place, Natasha N Frederick, Stephen E Sallan
Clinical Case Reports|May 31, 2023
Use of the osmolal gap in diagnosing mixed physiology hyponatremia in a child with B-cell acute lymphoblastic leukemiaJonathan M Gabbay, Andrew E Place, Maya Ilowite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Future of clinical genomics in pediatric oncologyKatherine A Janeway, Andrew E Place, Mark W Kieran, et al.
Journal of the Pediatric Infectious Diseases Society|October 12, 2019
Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus IncidenceManjiree V Karandikar, Carly E Milliren, Robin Zaboulian, et al.
British Journal of Haematology|March 21, 2022
Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemiaYannis K Valtis, Andrew E Place, Lewis B Silverman, et al.
Pediatric Blood & Cancer|February 21, 2022
Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemiaGiacomo Gotti, Kristen Stevenson, Samantha Kay-Green, et al.
Blood Advances|August 23, 2021
B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutationsKathryn A Six, Ulrike Gerdemann, Anna L Brown, et al.
Pediatric Blood & Cancer|June 22, 2022
Reply to: Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemiaGiacomo Gotti, Kristen Stevenson, Samantha Kay-Green, et al.
Cancer Medicine|September 8, 2025
Contemporary Characteristics and Outcomes of Pediatric Oncology Patients Participating in Early Phase Clinical TrialsAvina Rami, Kira Bona, Suzanne Shusterman, et al.
Pageof 6

Showing results (1-10 of 55) with videos related to

Sort By:
Pageof 6
Breast Cancer Research : BCR|November 15, 2011
The microenvironment in breast cancer progression: biology and implications for treatmentAndrew E Place, Sung Jin Huh, Kornelia Polyak
British Journal of Haematology|September 7, 2013
Therapeutic approaches to haematological malignancies in adolescents and young adultsAndrew E Place, Natasha N Frederick, Stephen E Sallan
Clinical Case Reports|May 31, 2023
Use of the osmolal gap in diagnosing mixed physiology hyponatremia in a child with B-cell acute lymphoblastic leukemiaJonathan M Gabbay, Andrew E Place, Maya Ilowite, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 17, 2013
Future of clinical genomics in pediatric oncologyKatherine A Janeway, Andrew E Place, Mark W Kieran, et al.
Journal of the Pediatric Infectious Diseases Society|October 12, 2019
Limiting Vancomycin Exposure in Pediatric Oncology Patients With Febrile Neutropenia May Be Associated With Decreased Vancomycin-Resistant Enterococcus IncidenceManjiree V Karandikar, Carly E Milliren, Robin Zaboulian, et al.
British Journal of Haematology|March 21, 2022
Orthopaedic adverse events among adolescents and adults treated with asparaginase for acute lymphoblastic leukaemiaYannis K Valtis, Andrew E Place, Lewis B Silverman, et al.
Pediatric Blood & Cancer|February 21, 2022
Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemiaGiacomo Gotti, Kristen Stevenson, Samantha Kay-Green, et al.
Blood Advances|August 23, 2021
B-cell acute lymphoblastic leukemia in patients with germline RUNX1 mutationsKathryn A Six, Ulrike Gerdemann, Anna L Brown, et al.
Pediatric Blood & Cancer|June 22, 2022
Reply to: Comment on: Ocular abnormalities at diagnosis and after the completion of treatment in children and adolescents with newly diagnosed acute lymphoblastic leukemiaGiacomo Gotti, Kristen Stevenson, Samantha Kay-Green, et al.
Cancer Medicine|September 8, 2025
Contemporary Characteristics and Outcomes of Pediatric Oncology Patients Participating in Early Phase Clinical TrialsAvina Rami, Kira Bona, Suzanne Shusterman, et al.
Pageof 6